ACE2 and COVID-19: The coronavirus receptor angiotensin-converting enzyme 2 (ACE2) has been recognized as an entry and interaction receptor (entry gate) for the SARS-CoV-2 virus [11], therefore, ACE2 has been accountable for the pathogenesis for COVID-19.